Drug maker Johnson & Johnson could face a wave of legal action after it was ordered to pay $8bn (£6.6bn) to a man who grew breasts after taking one of its medicines.
The US pharmaceutical giant was ordered to hand the punitive damages award to Nicholas Murray, who is understood to be one of thousands of individuals planning to take action.
Mr Murray, 26, developed breasts after doctors put him on anti-psychotic drug Risperdal as a teenager to treat autism spectrum disorder.
Johnson & Johnson plans to appeal the ruling by a Philadelphia court but faces further legal action by more than 13,000 claimants over its marketing of the drug and failure to warn young men about its health risks.
Start a 30-day free trial for unlimited access to Premium articles
- Unlimited access to Premium articles
- Subscriber-only events and experiences
- Cancel any time
Free for 30 days
then only £2 per week
Save 25% with an annual subscription
Just £75 per year